Sibyl directs the company’s research partnerships, clinical trials, regulatory matters, new product development and R&D. Prior to cbdMD, Sibyl was the SVP for Scientific & Regulatory Affairs at the Natural Products Association (NPA) and before joining NPA, she was the Associate Director for Research and Strategy at FDA’s ODSP where she directed the office’s research portfolio and was responsible for ensuring alignment between its science, research, compliance, enforcement, and policy initiatives. Sibyl is also the co-chair of cbdMD Therapeutics and a member of the board of Directors.